Contribution of protein G-related α2-macroglobulin-binding protein to bacterial virulence in a mouse skin model of group A streptococcal infection

Journal of Infectious Diseases

Volumn 187, Issue 11, 2003, Pages 1694-1703

  Toppel, Antonia W ^a   Rasmussen, Magnus ^b   Rohde, Manfred ^a   Medina, Eva ^a   Chhatwal, Gursharan Singh ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; BINDING PROTEIN; PROTEIN G RELATED ALPHA 2 MACROGLOBULIN BINDING PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MODEL; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SKIN DEFECT; SKIN INFECTION; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; SURVIVAL; SURVIVAL TIME; WILD TYPE;

ALPHA-MACROGLOBULINS; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MICE; MICE, INBRED BALB C; MUTATION; PROTEIN BINDING; SKIN; SKIN DISEASES, BACTERIAL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SURVIVAL ANALYSIS; TIME FACTORS; VIRULENCE;

EID: 0037864290     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/375029     Document Type: Article

References (48)

1. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13:470-511.
2. Sharkawy A, Low DE, Saginur R, et al. Severe group A streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis 2002; 34:454-60.
3. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996; 334:240-5.
4. Chelsom J, Halstensen A, Haga T, Hoiby EA. Necrotizing fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 1994; 344:1111-5.
5. Kaul R, McGeer A, Low DE, Green K, Schwartz B, Simor AE. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Am J Med 1997; 103:18-24.
6. Johnson DR, Wotton JT, Shet A, Kaplan EL. A comparison of group A streptococci from invasive and uncomplicated infections: are virulent clones responsible for serious streptococcal infections? J Infect Dis 2002; 185:1586-95.
7. Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DS. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun 1995; 63:994-1003.
8. Rasmussen M, Björck L. Proteolysis and its regulation at the surface of Streptococcus pyogenes. Mol Microbiol 2002; 43:537-44.
9. von Pawel-Rammingen U, Johansson BP, Björck L. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J 2002; 21:1607-15.
10. Svensson MD, Scaramuzzino DA, Sjöbring U, Olsén A, Frank C, Bessen DE. Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci. Mol Microbiol 2000; 38:242-53.
11. Ashbaugh CD, Wessels MR. Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection. Infect Immun 2001; 69:6683-6.
12. Ashbaugh CD, Warren HB, Carey VJ, Wessels MR. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest 1998; 102:550-60.
13. Raeder R, Harokopakis E, Hollingshead S, Boyle MDP. Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64. Infect Immun 2000; 68:744-51.
14. Lukomski S, Montgomery CA, Rurangirwa J, et al. Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect Immun 1999; 67:1779-88.
15. Wannamaker LW. The differentiation of three distinct desoxyribonucleases of group A streptococci. J Exp Med 1958; 107:797-812.
16. Hynes WL, Hancock L, Ferretti JJ. Analysis of a second bacteriophage hyaluronidase gene from Streptococcus pyogenes: evidence for a third hyaluronidase involved in extracellular enzymatic activity. Infect Immun 1995; 63:3015-20.
17. Tewodros W, Norgren M, Kronvall G. Streptokinase activity among group A streptococci in relation to streptokinase genotype, plasminogen binding, and disease manifestations. Microb Pathog 1995; 18:53-65.
18. Wang H, Lottenberg R, Boyle MDP. Analysis of plasmin(ogen) acquisition by clinical isolates of group A streptococci incubated in human plasma. J Infect Dis 1994; 169:143-9.
19. Wang H, Lottenberg R, Boyle MDP. Analysis of the interaction of group A streptococci with fibrinogen, streptokinase and plasminogen. Microb Pathog 1995; 18:153-66.
20. Wang H, Lottenberg R, Boyle MDP. A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci. J Infect Dis 1995; 171:85-92.
21. Christner R, Li Z, Raeder R, Podbielski A, Boyle MDP. Identification of key gene products required for acquisition of plasmin-like enzymatic activity by group A streptococci. J Infect Dis 1997; 175:1115-20.
22. Li Z, Ploplis VA, French EL, Boyle MDP. Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model. J Infect Dis 1999; 179:907-14.
23. Burns EH Jr, Marciel AM, Musser JM. Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease. Infect Immun 1996; 64:4744-50.
24. 2-macroglobulin to group G streptococci. Infect Immun 1983; 41:959-64.
25. 2-macroglobulin. J Bacteriol 1987; 169:3691-5.
26. 2-macroglobulin. J Biol Chem 1999; 274:15336-44.
27. 2-macroglobulin. J Biol Chem 1984; 259:8318-27.
28. 2-macroglobulin conformational variants by non-ideal high performance size-exclusion chromatography. Biochem J 1986; 235:559-67.
29. 2-macroglobulin in human plasma. Biol Chem Hoppe Seyler 1989; 370:673-6.
30. 2-macroglobulin monomers obtained by reduction with dithiothreitol. Biochemistry 1991; 30:1545-51.
31. Sjöbring U, Trojnar J, Grubb A, Åkerström B, Björck L. Ig-binding bacterial proteins also bind proteinase inhibitors. J Immunol 1989; 143:2948-54.
32. Sjöbring U, Björck L, Kastern W. Streptococcal protein G gene structure and protein binding properties. J Biol Chem 1991; 266:399-405.
33. 2-macroglobulin to human group G streptococci. Infect Immun 1995; 63:2833-9.
34. Podbielski A, Spellerberg B, Woischnik M, Pohl B, Luttiken R. Novel series of plasmid vectors for gene inactivation and expression analysis in group A streptococci (GAS). Gene 1996; 177:137-47.
35. Gardiner DL, Goodfellow AM, Martin DR, Sriprakash KD. Group A streptococcal Vir types are M-protein gene (emm) sequence type specific. J Clin Microbiol 1998; 36:902-7.
36. Goodfellow AM, Hibble M, Talay SR, et al. Distribution and antigenicity of fibronectin binding proteins (SfbI and SfbII) of Streptococcus pyogenes clinical isolates from the northern territory, Australia. J Clin Microbiol 2000; 38:389-92.
37. Hunter WH, Greenwood FC. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 1962; 194:495-6.
38. Lancefield RC. Current knowledge of type-specific M antigens of group A streptococci. J Immunol 1962; 89:307-13.
39. Ishizaka S, Kuriyama S, Tsujii T. In vivo depletion of macrophages by desulfated iota-carrageenan in mice. J Immunol Methods 1989; 124:17-24.
40. Machling RC. An inexpensive and reliable method of negative-pressure paraffin wax embedding. J Med Lab Technol 1969; 26:271.
41. Molinari G, Talay SR, Valentin-Weigand P, Rohde M, Chhatwal GS. The fibronectin-binding protein of Streptococcus pyogenes, Stb1, is involved in the internalization of group A streptococci by epithelial cells. Infect Immun 1997; 65:1357-63.
42. Medina E, Goldmann O, Rohde M, Lengeling A, Chhatwal GS. Genetic control of susceptibility to group A streptococcal infection in mice. J Infect Dis 2001; 184:846-52.
43. Scaramuzzino DA, McNiff JM, Bessen DE. Humanized in vivo model for streptococcal impetigo. Infect Immun 2000; 68:2880-7.
44. Smith JA. Neutrophils, host defence, and inflammation: a double-edged sword. J Leukoc Biol 1994; 56:672-86.
45. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320:365-76.
46. Saouda M, Wu W, Conran P, Boyle MDP. Streptococcal pyrogenic exotoxin B enhances tissue damage initiated by other Streptococcus pyogenes products. J Infect Dis 2001; 184:723-31.
47. Podbielski A, Schnitzler N, Beyhs P, Boyle MD. M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes. Mol Microbiol 1996; 19:429-41.
48. Song XM, Perez-Casal J, Bolton A, Potter AA. Surface-expressed Mig protein protects Streptococcus dysgalactiae against phagocytosis by bovine neutrophils. Infect Immun 2001; 69:6030-7.